Riyadh, Saudi Arabia — Nahdi Medical Company announced a cash dividend distribution of SAR 338 million for the first half of 2025, following Board approval, according to a disclosure on Tadawul.

Dividend Details and Payment Procedures

The payout amounts to SAR 2.60 per share, or 26% of the share’s nominal value. A total of 130 million shares are eligible for the distribution.

Shareholders recorded in the Securities Depository Center (Edaa) by the close of trading on Tuesday, August 12, 2025, will qualify. Payments will be transferred to eligible accounts on Monday, August 26, 2025.

Nahdi stressed that all dividends will be credited directly to bank accounts linked to shareholder portfolios. Investors should verify their account details to prevent any delay.

Non-resident investors are subject to a 5% withholding tax, as outlined under Article 68 of the Income Tax Law and Article 63 of its Implementing Regulations.

In addition, Nahdi encouraged shareholders with unclaimed dividends from previous periods to contact the Investor Relations department for support.

What This Means for Investors

  • Consistent returns: The SAR 2.60 per share payout confirms Nahdi’s reliable cash flow and shareholder commitment.
  • Clear distribution process: Edaa ensures direct, timely transfers with well-defined eligibility.
  • Regulatory alignment: Tax policies are clearly outlined, reinforcing compliance and investor transparency.
  • Sector confidence: The dividend reflects financial strength in Saudi Arabia’s healthcare retail sector.

 

 

THE SAUDI STANDARD’S VIEW: Nahdi’s SAR 338M Dividend Reinforces Healthcare Sector’s Cash Flow Strength and Investor Appeal

Nahdi Medical’s SAR 338 million dividend for H1 2025—equivalent to SAR 2.60 per share—demonstrates its standing as one of the Kingdom’s most consistent, cash-generating healthcare retailers.

The 26% distribution follows H1 net profits of SAR 493.6 million. This reflects Nahdi’s capacity to convert solid operations into meaningful shareholder returns.

With 130 million shares eligible, the payout confirms Nahdi’s financial stability. It also highlights the company’s ability to support dividends while expanding its retail footprint, scaling digital offerings, and entering regional markets such as the UAE.

Moreover, the seamless dividend process through Edaa and strict tax compliance show Nahdi’s governance strength and investor-first mindset—both key components of Saudi Arabia’s evolving capital market.

This announcement reinforces confidence in the Kingdom’s healthcare and consumer sectors. These segments continue to generate reliable income streams, aligning with Vision 2030’s ambition to attract long-term investment.

Ultimately, the Nahdi Medical H1 2025 dividend reflects financial resilience and a balanced growth strategy. As the Kingdom broadens healthcare access and strengthens its medical retail market, Nahdi stands out as a benchmark for operational excellence and shareholder value.

 

Related Reading

Explore the latest dividend declarations and shareholder updates in Saudi investment

Track healthcare company earnings and dividend actions on Tadawul